Vanguard Fiduciary Trust
LNAI

Vanguard Fiduciary Trust’s Lunai Bioworks LNAI Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Hold
8,642
– – ﹤0.01% 3949
2026
Q1 		$28.2K Buy
+8,642
New +$42.9K ﹤0.01% 3904

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust's LNAI Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Lunai Bioworks (LNAI) position steady in Q2 2026 at 8,642 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3949.

Vanguard Fiduciary Trust first reported a position in LNAI in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Vanguard Fiduciary Trust held 8,642 shares of Lunai Bioworks worth $28.3K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Lunai Bioworks share count unchanged in Q2 2026.
  • Lunai Bioworks made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3949 holding.
  • Vanguard Fiduciary Trust first reported a position in Lunai Bioworks in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.